119 related articles for article (PubMed ID: 11299747)
1. Tumor-specific action of sodium 5,6-benzylidene-L-ascorbate in N-nitrosodiethylamine-administered mouse model.
Asano K; Satoh K; Kochi M; Kusama K; Sakagami H
Anticancer Res; 2001; 21(1A):281-4. PubMed ID: 11299747
[TBL] [Abstract][Full Text] [Related]
2. Production of hydrogen peroxide in cancerous tissue by intravenous administration of sodium 5,6-benzylidene-L-ascorbate.
Asano K; Satoh K; Hosaka M; Arakawa H; Inagaki M; Hisamitsu T; Maeda M; Kochi M; Sakagami H
Anticancer Res; 1999; 19(1A):229-36. PubMed ID: 10226547
[TBL] [Abstract][Full Text] [Related]
3. Role of hydrogen peroxide in antitumor activity induction by sodium 5,6-benzylidene-L-ascorbate.
Sakagami H; Hosaka M; Arakawa H; Maeda M; Satoh K; Ida Y; Asano K; Hisamitsu T; Takimoto M; Ota H; Inagaki M; Sasuga K; Sho S; Tanaka T; Utsumi N; Oi T; Kochi M
Anticancer Res; 1998; 18(4A):2519-24. PubMed ID: 9703903
[TBL] [Abstract][Full Text] [Related]
4. Changes in intracellular concentrations of amino acids and polyamines during the apoptosis of HL-60 cells.
Sakagami H; Fujiwara E; Yokote Y; Akahane K; Asano K; Kochi M; Hara E; Shirahata A
Anticancer Res; 2000; 20(1A):265-70. PubMed ID: 10769665
[TBL] [Abstract][Full Text] [Related]
5. Interaction between sodium 5,6-benzylidene-L-ascorbate and dopamine.
Satoh K; Ida Y; Kochi M; Sakagami H
Anticancer Res; 1998; 18(5A):3565-9. PubMed ID: 9858940
[TBL] [Abstract][Full Text] [Related]
6. Interaction between sodium 5,6-benzylidene-L-ascorbate and gallic acid.
Koyama N; Satoh K; Ida Y; Hiroi M; Oi T; Kochi M; Yamamoto Y; Sakagami H
Anticancer Res; 1999; 19(2A):1159-64. PubMed ID: 10368669
[TBL] [Abstract][Full Text] [Related]
7. Comparative study of the antitumor action between sodium 5,6-benzylidene-L-ascorbate and sodium ascorbate (minireview).
Sakagami H; Satoh K; Kochi M
Anticancer Res; 1997; 17(6D):4451-2. PubMed ID: 9494548
[TBL] [Abstract][Full Text] [Related]
8. Effect of physiological fluids on radical intensity of sodium ascorbate and sodium 5,6-benzylidene-L-ascorbate.
Satoh K; Ida Y; Asano K; Hisamitsu T; Inagaki M; Sho S; Kochi M; Tanaka T; Sakagami H
Anticancer Res; 1997; 17(6D):4457-61. PubMed ID: 9494550
[TBL] [Abstract][Full Text] [Related]
9. Tumor-specific cytotoxicity and type of cell death induced by sodium 5,6-benzylidene-L-ascorbate.
Kishino K; Hashimoto K; Amano O; Kochi M; Liu WK; Sakagami H
Anticancer Res; 2008; 28(5A):2577-84. PubMed ID: 19035281
[TBL] [Abstract][Full Text] [Related]
10. Effect of cysteine, N-acetyl-L-cysteine and glutathione on cytotoxic activity of antioxidants.
Satoh K; Sakagami H
Anticancer Res; 1997; 17(3C):2175-9. PubMed ID: 9216683
[TBL] [Abstract][Full Text] [Related]
11. Induction of DNA fragmentation in human myelogenous leukemic cell lines by sodium 5,6-benzylidene-L-ascorbate and its related compounds.
Kuribayashi N; Sakagami H; Sakagami T; Niimi E; Shiokawa D; Ikekita M; Takeda M; Tanuma S
Anticancer Res; 1994; 14(3A):969-76. PubMed ID: 8074500
[TBL] [Abstract][Full Text] [Related]
12. Effect of sodium benzylideneascorbate on chemically-induced tumors in rats.
Sakagami H; Takeda M; Utsumi A; Fujinaga S; Tsunoda A; Yasuda N; Shibusawa M; Koike T; Ota H; Kazama K
Anticancer Res; 1993; 13(1):65-71. PubMed ID: 8386496
[TBL] [Abstract][Full Text] [Related]
13. Mitochondrial control of cell death induction by sodium 5,6-benzylidene-L-ascorbate.
Fujii H; Amano O; Kochi M; Sakagami H
Anticancer Res; 2003; 23(2B):1353-6. PubMed ID: 12820394
[TBL] [Abstract][Full Text] [Related]
14. Stability of sodium 5,6-benzylidene-L-ascorbate.
Sakagami H; Yamamura TS; Takahashi H; Shibuya I; Takeda M
Anticancer Res; 1995; 15(4):1269-74. PubMed ID: 7654007
[TBL] [Abstract][Full Text] [Related]
15. Effect of cobalt ion on radical intensity and cytotoxic activity of antioxidants.
Sakagami T; Satoh K; Ishihara M; Sakagami H; Takeda F; Kochi M; Takeda M
Anticancer Res; 2000; 20(5A):3143-50. PubMed ID: 11062735
[TBL] [Abstract][Full Text] [Related]
16. Induction of tumor degeneration by sodium benzylideneascorbate.
Sakagami H; Asano K; Fukuchi K; Gomi K; Ota H; Kazama K; Tanuma S; Kochi M
Anticancer Res; 1991; 11(4):1533-8. PubMed ID: 1746910
[TBL] [Abstract][Full Text] [Related]
17. Relationship between ascorbyl radical intensity and apoptosis-inducing activity.
Sakagami H; Satoh K; Ohata H; Takahashi H; Yoshida H; Iida M; Kuribayashi N; Sakagami T; Momose K; Takeda M
Anticancer Res; 1996; 16(5A):2635-44. PubMed ID: 8917363
[TBL] [Abstract][Full Text] [Related]
18. Sodium 5, 6-benzylidene-L-ascorbate induces in vitro neuronal cell differentiation accompanying apoptosis and necrosis.
Tashiro F; Sugiyama A; Urano Y; Kochi M
Anticancer Res; 2002; 22(3):1423-31. PubMed ID: 12168819
[TBL] [Abstract][Full Text] [Related]
19. Effect on protein synthesis and cell survival of the benzaldehyde derivatives sodium benzylidene ascorbate (SBA) and the deuterated compound zilascorb(2H).
Pettersen EO; Larsen RO; Boerretzen B; Dornish JM; Oftebro R
Anticancer Res; 1991; 11(3):1077-81. PubMed ID: 1888141
[TBL] [Abstract][Full Text] [Related]
20. Production of hydrogen peroxide and methionine sulfoxide by epigallocatechin gallate and antioxidants.
Sakagami H; Arakawa H; Maeda M; Satoh K; Kadofuku T; Fukuchi K; Gomi K
Anticancer Res; 2001; 21(4A):2633-41. PubMed ID: 11724332
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]